Plain-English translation of NCT05885646 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is exploring how a medication called affects brain wave patterns in children with epilepsy that activates during sleep. Researchers will measure your child's brain activity using EEG (a recording of electrical activity in the brain) at the start of the study and again after 2 and 4 weeks of taking the medication. The goal is to see whether the medication can reduce abnormal brain activity patterns that happen during sleep.
Many children with this type of epilepsy don't respond well to standard anti-seizure drugs. This medication has shown promise in the past, but researchers want to understand how quickly it works and whether its benefits show up early in treatment.
You likely qualify if…
You likely don't qualify if…
Your child will take the medication as prescribed while continuing any other seizure medications they're already on. You'll return for brain wave recordings (EEG) at two time points: after 2 weeks and after 4 weeks of starting the medication. These recordings typically happen during sleep and help doctors see whether the medication is reducing the abnormal brain activity patterns. The study lasts about 4 weeks total.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
France